Exclusive Skincare Launch for the Next Generation of Peptides

Description​

Exclusive Skincare Launch for the Next Generation of Peptides

Cells within the skin are constantly communicating with each other. They have to sense their environment and work collectively to respond in the right way.

Cells have their own means of sending and receiving signals and are always on the look out. Advanced skincare understands these signalling mechanisms and uses them to provide anti-inflammatory, wound healing, and re-building messages to skin cells.

Most of us have heard of peptides, but newer technology is taking peptides signalling a step further and producing outstanding scientific results.

EVENSWISS is the creator of a groundbreaking and patented signalling technology called Dermatopoietin.

Dermatopoietin, which is equivalent to a polypeptide naturally found in human skin called ​ interleukin-1-alpha, starts a cascade of signals from the surface of the skin and into the dermis.

These signals generate a strong increase in collagen, elastin, and hyaluronic acid – by up to 90% in 2 weeks.

The technology is backed by 6 clinical trials that show statistically significant improvements in fine lines and wrinkles, skin density, under eye bags, cellulite, and hair loss.

Conventional antiaging products are limited by the poor penetration of the skin barrier and therefore have minor effects in the dermis. ​ They include chemical penetration enhancers which can facilitate the penetration of pollutants and microorganisms into the skin.

Dermatopoietin is a first-of-its-kind technology that does not need to penetrate the skin in order to work. ​ The technology gives a message to outer skin cells which allows them to generate signals within the skin for regeneration.

Scroll to Top

Trends Report 2021

ExCeL London | 14 & 15 October 2021

CCR’s all new press conference discussing the industry’s current trends in surgical and non-surgical aesthetics!